Answers are grounded in this paper and cite their sources.
Recent advances in radiopharmaceutical therapy (RPT) and radioembolization (RE) will make these forms of therapy more prevalent in radiation oncology and nuclear medicine clinics. This article guides medical physicists in radiation oncology by summarizing current RPT and RE techniques, processes, safety, quality assurance, equipment, and others. The summarized guidance, which addresses technical considerations, may be applied broadly to develop a clinical RPT/RE program that offers multiple types of such therapies.
No takes yet. Share an insight, caveat, or question.
Polignani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: